A
ADPT
Adaptive Biotechnologies
12.79
-0.61-4.55%After Hours: 12.79 0.00 0.00%18:56 04/10 EDT
OPEN/PREV CLOSE13.43/13.40
TODAY RANGE12.36-13.60
VOL3.31M
MARKET CAP1.97B
52 WEEK RANGE6.71-20.76
AVG VOL (3M)2.03M
% TURNOVER2.15%
TURNOVER--
P/E (TTM)-32.6109
% RANGE9.25%
EPS(TTM)-0.3922
P/E(FORWARD)-26.3711
P/B8.99
BVPS1.423
DIVIDEND--
P/S7.10
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.93B
SHARES OUTSTANDING153.98M
NEXT EARNINGS04/29-05/04
FREE FLOAT150.54M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings
Simply Wall St·5d ago
Adaptive Biotechnologies (ADPT) Is Up 15.3% After Beating Q4 Views And Striking Pfizer Deals
Simply Wall St·6d ago
A Look At Adaptive Biotechnologies (ADPT) Valuation After Strong 1 Year Share Price Performance
Simply Wall St·04/02 11:30
Is It Time To Reassess Adaptive Biotechnologies (ADPT) After Its Volatile Share Price Run
Simply Wall St·03/31 21:12
Insider Sale At Adaptive Biotechnologies Versus clonoSEQ Growth And Valuation
Simply Wall St·03/28 07:07
A Look At Adaptive Biotechnologies (ADPT) Valuation After Recent Share Price Weakness
Reuters·03/25 00:51
Adaptive Biotechnologies launches clonoSEQ MRD test for blood cancers
Simply Wall St·03/19 19:10
Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong Q4 Results And MRD Growth
Same Industry
Name/Symbol
Change%
Price